November 5, 2012
Many are now aware that studies and reports indicate Yaz and Yasmin birth control pills present a higher risk of blood clots to women. Yaz and its predecessor, Yasmin, (in addition to Yasmin's generic equivalent, Ocella) are among some of the newer birth control pills that contain drospirenone, a manmade hormone which mimics the naturally occurring progesterone. The risks associated with these types of pills are grave, as blood clots can lead to blockages within blood vessels and lungs, strokes, and even heart attacks.
While a rising wave of litigation has generated public awareness concerning the risks associated with Yaz and Yasmin, the vaginal birth control ring known as NuvaRing is now also the focus of a number of lawsuits. The lawsuits related to NuvaRing are not as profuse, perhaps in part due to the popularity of the birth control pill over the ring. However, NuvaRing is now under heavy scrutiny for allegedly also placing women at increased risks for blood clots, deep vein thrombosis (DVT), stroke, or pulmonary embolisms. In October of 2011, the FDA released a combination contraceptive study , finding in part that combination birth control rings significantly increase one's risk for venous thromboembolism (a disease which includes deep venous thrombosis and pulmonary embolisms). In May of this year, the British Medical Journalalso published a study from Denmark, linking vaginal rings to as high as a 90% increased risk of blood clots when compared to combined oral contraceptives containing levonorgestrel.
Those women who have experienced blood clots, strokes, or heart attacks while using Yaz , Yasmin, or NuvaRing are reminded not to delay in exploring their legal options. In August of this year, the Appellate Division of the New Jersey Superior Court dismissed the case of Millian v. Organon USA Inc., et al, in which Ms. Millian filed a claim related to NuvaRing and her development of blood clots. The Court found Ms. Millian's claim was time barred, because she failed to file suit within two years of being informed by her doctors that her injuries were likely caused by NuvaRing. Accordingly, O'Mara and Padilla encourages women who have developed the above described health conditions while using these contraceptives not to hesitate in contacting our law offices for a free legal consultation.
Tagged as: BirthControl Litigation